The Women’s Health Science Program, now in its 11th year, provides hands-on laboratory and clinical experiences to young women who are considering careers in science and medicine.
Browsing: Roger Anderson
Northwestern Medicine scientists have discovered that children with a rare breathing disorder have a diminished rather than absent response to changes in oxygen and carbon dioxide levels within their bloodstream. The finding was recently published in the Journal of Applied Physiology.
A recently published Northwestern Medicine study uses math models based on the physical interactions within cells to make predictions of how gene transcription might be effected.
Radioembolization may offer an alternative to chemotherapy for breast cancer patients whose tumors have spread to the liver.
Rosalind Ramsey-Goldman, MD, professor of Medicine-Rheumatology, recently published a paper in the American Journal of Cardiology that links plaque in the carotid artery of women with lupus to an increased risk of cardiovascular events.
One of more than a dozen connected papers to be published in the American Journal of Public Health, a recent study has shown that Lesbian, Gay, Bisexual or Transgender youths make an increased number of choices that elevate their risk of cancer.
David Kamp, MD, completed his residency and fellowship at Northwestern, where he now studies a range of lung disorders as well as cellular apoptosis, a process of programmed cell death.
A new study has found that large racial/ethnic disparities in colorectal cancer screening persist in America, including substantial differences between English-speaking and Spanish-speaking Hispanics. The research confirmed continued low screening rates among all residents of the U.S.
Recently published research in Human Molecular Genetics shows that removing too much of the enzyme HDAC3 has a toxic effect on the nervous system. The expression of this enzyme is inhibited by drugs being studied as potential treatment options for cancer and neurodegeneration
Findings published by Northwestern Medicine scientists in Molecular Cell suggest that the upregulation of protein WDR5 may be crucial in prostate cancer development.